AU2005260090B2 - Lubricant for the ocular surface - Google Patents

Lubricant for the ocular surface Download PDF

Info

Publication number
AU2005260090B2
AU2005260090B2 AU2005260090A AU2005260090A AU2005260090B2 AU 2005260090 B2 AU2005260090 B2 AU 2005260090B2 AU 2005260090 A AU2005260090 A AU 2005260090A AU 2005260090 A AU2005260090 A AU 2005260090A AU 2005260090 B2 AU2005260090 B2 AU 2005260090B2
Authority
AU
Australia
Prior art keywords
wax
jojoba
group
eye
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2005260090A
Other languages
English (en)
Other versions
AU2005260090A1 (en
Inventor
Steven Maskin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MELBJ Holdings LLC
Original Assignee
MELBJ Holdings LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MELBJ Holdings LLC filed Critical MELBJ Holdings LLC
Publication of AU2005260090A1 publication Critical patent/AU2005260090A1/en
Application granted granted Critical
Publication of AU2005260090B2 publication Critical patent/AU2005260090B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Eyeglasses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2005260090A 2004-03-12 2005-03-01 Lubricant for the ocular surface Ceased AU2005260090B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US55247704P 2004-03-12 2004-03-12
US60/552,477 2004-03-12
US56268304P 2004-04-15 2004-04-15
US60/562,683 2004-04-15
PCT/US2005/006737 WO2006004577A2 (en) 2004-03-12 2005-03-01 Lubricant for the ocular surface

Publications (2)

Publication Number Publication Date
AU2005260090A1 AU2005260090A1 (en) 2006-01-12
AU2005260090B2 true AU2005260090B2 (en) 2008-06-05

Family

ID=35311617

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005260090A Ceased AU2005260090B2 (en) 2004-03-12 2005-03-01 Lubricant for the ocular surface

Country Status (5)

Country Link
EP (1) EP1727565A2 (ja)
JP (1) JP2007528897A (ja)
AU (1) AU2005260090B2 (ja)
CA (1) CA2559503A1 (ja)
WO (1) WO2006004577A2 (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2451452A (en) * 2007-07-30 2009-02-04 Donald Henry Yates A lubricant formulation
US20130023575A1 (en) * 2011-07-22 2013-01-24 Kamran Hosseini Compositions and methods for the treatment of ocular surface allergies
ITFI20120044A1 (it) * 2012-03-01 2013-09-02 Biodue Spa Formulazione ad uso oftalmico comprendente olio di jojoba.
JP5989365B2 (ja) * 2012-03-19 2016-09-07 ロート製薬株式会社 コンタクトレンズ用眼科組成物
AU2012388711B2 (en) * 2012-08-31 2015-12-17 Bausch & Lomb Incorporated Ophthalmic compositions with omega-3 fatty acids
WO2014116787A1 (en) * 2013-01-24 2014-07-31 Bausch & Lomb Incorporated Poly(nitrogen/amine) derivatives of a natural wax and ophthalmic compositions
JP6497812B2 (ja) * 2013-06-28 2019-04-10 学校法人慶應義塾 マイボーム腺機能不全の処置剤
AU2016222902A1 (en) * 2015-02-24 2017-08-31 Ocugen, Inc. Methods and compositions for treating dry eye disease and other eye disorders
CN105749360B (zh) * 2016-03-28 2019-06-18 赛克赛斯生物科技股份有限公司 一种保护角膜的组合物及其制备方法与应用
CN109689161A (zh) * 2016-08-19 2019-04-26 阿克里维斯塔有限责任公司 诊断和治疗干眼综合症的方法以及用于治疗人眼的组合物
EP3624773A4 (en) 2017-05-19 2021-04-07 Ocugen, Inc. OPHTHALMIC COMPOSITIONS AND METHOD OF USE
GB2580226B (en) * 2017-06-30 2022-08-31 Jenivision Inc Formulations for hair growth
CA3072494A1 (en) 2017-08-18 2019-02-21 Akrivista, LLC Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
US11278493B2 (en) 2018-12-10 2022-03-22 EternaTear, Inc. Ophthalmic formulations providing durable ocular lubrication
KR102221500B1 (ko) * 2019-06-10 2021-03-04 인제대학교 산학협력단 베타-카로틴을 포함하는 청색광 차단용 콘텍트 렌즈의 제조방법
US11471475B1 (en) 2022-03-08 2022-10-18 Ralph P. Stone Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
US11679078B1 (en) 2022-03-08 2023-06-20 EternaTear, Inc. Ophthalmic formulations and related methods

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0053554A1 (fr) * 1980-12-02 1982-06-09 INSTITUT DE RECHERCHES DE LA SIDERURGIE FRANCAISE (IRSID) France Procédé de réalisation de fonds de récipients métallurgiques
EP0875244A2 (en) * 1997-05-02 1998-11-04 Ciba SC Holding AG Cosmetically accceptable microstructured compositions
WO2002051379A2 (en) * 2000-12-23 2002-07-04 Impetus Ag Thixotropic nasal spray
US20030008022A1 (en) * 2001-07-07 2003-01-09 Mogy Nabil Sadek El Medical effect of jojoba oil

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
US6559182B1 (en) * 2001-11-07 2003-05-06 Purcell Jojoba International, Llc Method for treatment of enveloped viruses using jojoba oil esters

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0053554A1 (fr) * 1980-12-02 1982-06-09 INSTITUT DE RECHERCHES DE LA SIDERURGIE FRANCAISE (IRSID) France Procédé de réalisation de fonds de récipients métallurgiques
EP0875244A2 (en) * 1997-05-02 1998-11-04 Ciba SC Holding AG Cosmetically accceptable microstructured compositions
WO2002051379A2 (en) * 2000-12-23 2002-07-04 Impetus Ag Thixotropic nasal spray
US20030008022A1 (en) * 2001-07-07 2003-01-09 Mogy Nabil Sadek El Medical effect of jojoba oil

Also Published As

Publication number Publication date
EP1727565A2 (en) 2006-12-06
JP2007528897A (ja) 2007-10-18
AU2005260090A1 (en) 2006-01-12
WO2006004577A2 (en) 2006-01-12
CA2559503A1 (en) 2006-01-12
WO2006004577A3 (en) 2006-07-20

Similar Documents

Publication Publication Date Title
AU2005260090B2 (en) Lubricant for the ocular surface
US20050202097A1 (en) Lubricant for the ocular surface
US8906427B2 (en) Treatment for meibomian gland dysfunction or obstruction
EP2501388B1 (en) Use of prostaglandins f2alpha and analogues for the healing of corneal and conjunctival lesions
CA2880027C (en) Progesterone compositions and treatment for eye diseases and disorders
JPS58172314A (ja) ピロロピロール類を含む眼病用薬剤調製物
EP1754491B1 (en) Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist
US10973758B2 (en) Methods of eye treatment using therapeutic compositions containing dipyridamole
KR102256185B1 (ko) 멜라닌 및 멜라닌 유사체, 전구체, 및 유도체로 안과 질병, 질환, 및 증상의 치료 및 예방을 위한 방법
AU2014229371B2 (en) Compositions for use in treating eye disorders using dipyridamole
WO2013046059A2 (en) Methods and compositions for tamarind-based ocular disease treatment in combination with trehalose
JP4475802B2 (ja) 緑内障の局所治療用フルナリジンの使用法
ZA200607607B (en) Lubricant for the ocular surface
KR20070018755A (ko) 무스카린 수용체 작동약을 함유한 안과용 경피흡수형 제제
AU770365B2 (en) The process for manufacturing formulation of topical beta blockers with improved efficacy
US20240180826A1 (en) Opthalmic Compositions for Dry Eye Treatment and Methods of Manufacture of the Same

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired